mutation was being monitored by physicians at a multidisciplinary genetic predisposition clinic. He demonstrated no evidence of recurrent pleuropulmonary blastoma, and his renal US, chest radiographic, and ocular screening examination results remained normal. Per age-directed screening guidelines, he underwent thyroid US (Figs 1-3). He had no signs or symptoms of hyper- or hypothyroidism. Physical examination was notable for the absence of thyromegaly or palpable nodule. US at 12-month follow-up showed no change in size or appearance of the left lobe (not shown). However, at this time, the Thyroid Imaging Reporting and Data System (TI-RADS) classification scheme was applied to the stable left lobe finding. The findings were discussed at a multidisciplinary thyroid nodule conference, and the decision was made to bring the patient back for a short-term follow-up for limited unenhanced MRI without sedation (Fig 4). A diagnosis was made based on the follow-up imaging findings.
Keyphrases
- high resolution
- primary care
- magnetic resonance imaging
- machine learning
- deep learning
- mental health
- physical activity
- contrast enhanced
- case report
- big data
- emergency department
- gene expression
- genome wide
- intensive care unit
- computed tomography
- clinical practice
- mechanical ventilation
- replacement therapy
- dna methylation
- fluorescence imaging
- magnetic resonance
- artificial intelligence
- depressive symptoms
- copy number
- photodynamic therapy
- visible light
- drug induced